Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry of Bleeding Risk in Real World Chinese Acute Coronary Syndrome Patients-II

NCT03402711 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT03402711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03402711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry of Bleeding Risk in Real World Chinese Acute Coronary Syndrome Patients-II
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 14, 2017
Completion date
April 30, 2021
Enrollment
5,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, bleeding, percutaneous coronary intervention